Roche Holding AG (RHO)
XETR
394.20
+7.60 (+1.97%)
Closed
Oct 9, 2026
Day's Range
390.00394.20
52 wk Range
292.20420.80
Financial Statements - RHO - Roche Holding AG
Revenue
63.35B▲ 1.5%
Net Income
13.79B▲ 50.2%Net Margin 21.8%
EBITDA
22.21B▲ 32.8%
Free Cash Flow
13.07B▼ 13.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 63.35B | 62.39B | 60.44B | 70.38B |
| Cost of Goods | 16.64B | 16.28B | 16.35B | 21.10B |
| Gross Profit | 46.71B | 46.11B | 44.08B | 49.27B |
 Operating Expense | - | - | - | - |
| Operating Income | 18.47B | 13.41B | 15.39B | 18.68B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 16.97B | 11.79B | 14.07B | 17.46B |
| Income Tax | 3.17B | 2.60B | 1.72B | 2.99B |
| Net Income | 13.79B | 9.18B | 12.35B | 14.47B |
| EPS Basic | 16.18 | 10.39 | 14.4 | 15.52 |
| EPS Diluted | 16.04 | 10.31 | 14.31 | 15.37 |
| Basic Shares Outstanding | 796M | 797M | 799M | 855.51M |
| Diluted Shares Outstanding | 796M | 797M | 799M | 855.51M |
| Ebit | 18.31B | 13.19B | 15.07B | 18.19B |
| Ebitda | 22.21B | 16.72B | 18.65B | 23.01B |
| Net Income Continuous Operations | 13.79B | 9.18B | 12.35B | 14.47B |
| Minority Interests | -919M | -910M | -860M | -1.11B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
